Headlands Technologies LLC Adaptive Biotechnologies Corp Transaction History

Headlands Technologies LLC

  • $834 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 02, 2024
SELL
$3.46 - $5.33 $3,397 - $5,234
-982 Reduced 35.07%
1,818 $8,000
Q3 2023

Nov 09, 2023
SELL
$5.07 - $8.44 $34,131 - $56,818
-6,732 Reduced 70.63%
2,800 $15,000
Q2 2023

Aug 03, 2023
BUY
$6.19 - $8.78 $59,003 - $83,690
9,532 New
9,532 $63,000

Others Institutions Holding ADPT

# of Institutions
202
Shares Held
146M
Call Options Held
68.8K
Put Options Held
42.5K
View Full List

About Adaptive Biotechnologies Corp

ADPT Quotes by TradingView
  • Ticker ADPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 142,872,992
  • Market Cap $849M
  • Description
  • Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...
More about ADPT
Track This Portfolio

Track Headlands Technologies LLC Portfolio

Follow Headlands Technologies LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Headlands Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Headlands Technologies LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email